E Fund Management Co., Ltd. Vertex Pharmaceuticals Inc Transaction History

E Fund Management Co., Ltd.

$1.93 Billion
Q3 2024

A detailed history of E Fund Management Co., Ltd. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 5,405 shares of VRTX stock, worth $2.21 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

5,405

Previous 5,290 2.17%

Holding current value

$2.21 Million

Previous $2.48 Million 1.37%

% of portfolio

0.13%

Previous 0.14%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$460.0 - $505.78 $52,900 - $58,164	115 Added 2.17%	5,405 $2.51 Million
Q2 2024 Aug 12, 2024	BUY	$392.81 - $485.53 $416,771 - $515,147	1,061 Added 25.09%	5,290 $2.48 Million
Q1 2024 May 13, 2024	SELL	$407.69 - $446.08 $49,738 - $54,421	-122 Reduced 2.8%	4,229 $1.77 Million
Q4 2023 Feb 06, 2024	SELL	$343.0 - $410.68 $26,754 - $32,033	-78 Reduced 1.76%	4,351 $1.77 Million
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $148,122 - $158,757	438 Added 10.97%	4,429 $1.54 Million
Q2 2023 Aug 11, 2023	SELL	$314.42 - $351.91 $144,318 - $161,526	-459 Reduced 10.31%	3,991 $1.4 Million
Q1 2023 May 11, 2023	SELL	$283.23 - $323.1 $50,981 - $58,158	-180 Reduced 3.89%	4,450 $1.4 Million
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $2.01 Million - $2.26 Million	-7,018 Reduced 60.25%	4,630 $1.34 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $1.81 Million - $2.01 Million	6,592 Added 130.38%	11,648 $3.37 Million
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $126,643 - $157,684	539 Added 11.93%	5,056 $1.43 Million
Q1 2022 May 12, 2022	BUY	$221.42 - $260.97 $21,920 - $25,836	99 Added 2.24%	4,517 $1.18 Million
Q4 2021 Feb 11, 2022	SELL	$177.01 - $223.45 $29,737 - $37,539	-168 Reduced 3.66%	4,418 $970,000
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $76,365 - $85,458	421 Added 10.11%	4,586 $832,000
Q1 2021 May 12, 2021	BUY	$207.02 - $241.31 $862,238 - $1.01 Million	4,165 New	4,165 $895,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on E Fund Management Co., Ltd. with notifications on news.

Account

E Fund Management Co., Ltd. Vertex Pharmaceuticals Inc Transaction History